- Home
- TMO
as 11-06-2025 3:49pm EST
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
| Founded: | 1956 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 201.9B | IPO Year: | N/A |
| Target Price: | $611.19 | AVG Volume (30 days): | 1.8M |
| Analyst Decision: | Buy | Number of Analysts: | 17 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 17.32 | EPS Growth: | 8.54 |
| 52 Week Low/High: | $385.46 - $610.97 | Next Earning Date: | 10-22-2025 |
| Revenue: | $43,736,000,000 | Revenue Growth: | 3.22% |
| Revenue Growth (this year): | 4.28% | Revenue Growth (next year): | 5.00% |
Stock Insider Trading Activity of Thermo Fisher Scientific Inc (TMO)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| CASPER MARC N | TMO | Chairman & CEO | Oct 27 '25 | Sell | $566.71 | 7,250 | $4,104,241.78 | 120,903.285 | |
| CASPER MARC N | TMO | Chairman & CEO | Oct 24 '25 | Sell | $573.23 | 17,104 | $9,809,862.02 | 120,903.285 | |
| Pettiti Gianluca | TMO | Executive Vice President | Oct 24 '25 | Sell | $574.15 | 400 | $229,660.00 | 21,152.223 | |
| CASPER MARC N | TMO | Chairman & CEO | Sep 5 '25 | Sell | $500.67 | 400 | $200,201.00 | 120,903.285 | |
| Holmes Joseph R. | TMO | VP & Chief Accounting Officer | Aug 29 '25 | Sell | $492.62 | 385 | $189,661.91 | 2,318.982 | |
| CASPER MARC N | TMO | Chairman & CEO | Aug 22 '25 | Sell | $501.44 | 10,000 | $5,009,586.03 | 120,903.285 | |
| CASPER MARC N | TMO | Chairman & CEO | Aug 20 '25 | Sell | $500.07 | 295 | $147,512.35 | 120,903.285 | |
| CASPER MARC N | TMO | Chairman & CEO | Aug 19 '25 | Sell | $500.17 | 201 | $100,533.59 | 120,903.285 |
Latest Thermo Fisher Scientific Inc News
TMO Breaking Stock News: Dive into TMO Ticker-Specific Updates for Smart Investing
Insider Monkey
a day ago
Diamond Hill Capital Large Cap Fund Added Thermo Fisher Scientific (TMO) on a Dip
GlobeNewswire
3 days ago
Cas12 Protein Market Report 2025: Market Led by Thermo Fisher, Bio-Techne and IDT, With APAC Set for Fastest Growth Despite Trade-Driven Supply Challenges - Global Forecast to 2029 and 2034
GlobeNewswire
3 days ago
Methyl Acetate Industry Research and Global Forecast Report 2025-2030: Lucrative Opportunities in Expanding Applications Across High-Growth Industries, & Growth Through Bio-based and Circular Economy
Insider Monkey
4 days ago
Here’s Why Baron Health Care Fund Added Thermo Fisher Scientific (TMO) to Its Portfolio
Simply Wall St.
5 days ago
Investors in Thermo Fisher Scientific (NYSE:TMO) have seen returns of 15% over the past three years
GlobeNewswire
8 days ago
Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting
MT Newswires
9 days ago
Sector Update: Health Care Stocks Fall Late Afternoon
MT Newswires
9 days ago
Sector Update: Health Care Stocks Softer Wednesday Afternoon
Compare TMO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TMO Thermo Fisher Scientific Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.